These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11340276)

  • 1. The role of intraductal carcinoma in the natural history of prostatic adenocarcinoma.
    McNeal JE
    Eur Urol; 2001 Apr; 39 Suppl 4():4. PubMed ID: 11340276
    [No Abstract]   [Full Text] [Related]  

  • 2. Cribriform and glomeruloid acinar adenocarcinoma of the prostate-an intratumoural intraductal carcinoma?
    Tolkach Y; Kristiansen G
    Histopathology; 2019 May; 74(6):804-808. PubMed ID: 31006895
    [No Abstract]   [Full Text] [Related]  

  • 3. Papillary adenocarcinoma of prostate.
    Scott MB; Goldstein AM; Onofrio RC; Cosgrove MD
    Urology; 1976 Sep; 8(3):227-30. PubMed ID: 184573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
    Robinson BD; Epstein JI
    J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal adenocarcinoma of the prostate.
    Cohen RJ; O'Brien BA; Wheeler TM
    Hum Pathol; 2011 Apr; 42(4):605-6; author reply 606-7. PubMed ID: 21237485
    [No Abstract]   [Full Text] [Related]  

  • 7. In Reply: Intraductal Carcinoma of the Prostate and Nuclear Size.
    Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
    Am J Surg Pathol; 2022 Sep; 46(9):1315-1317. PubMed ID: 35778794
    [No Abstract]   [Full Text] [Related]  

  • 8. Acinar Adenocarcinoma of Prostate with Predominant Ttf-1 Positive Intraductal Component.
    Sarsik B; Karadeniz N; Şimşir A; Akyol R; Yörükoğlu K; Şen S
    Turk Patoloji Derg; 2017; 33(1):70-73. PubMed ID: 28044303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological pattern in prostatic adenocarcinomas: is it a prognostic criterion?
    Bircan K; Başar I; Ergen A; Tekgül S; Ozbay G; Ozen HA
    Int Urol Nephrol; 1991; 23(1):57-64. PubMed ID: 1657811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic adenocarcinoma of ductal origin.
    Greene LF; Farrow GM; Ravits JM; Tomera FM
    J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Carcinoma of the Prostate.
    Humphrey PA
    J Urol; 2015 Nov; 194(5):1434-5. PubMed ID: 26291925
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic adenocarcinoma of ductal origin.
    Dube VE; Farrow GM; Greene LF
    Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraductal carcinoma of prostate: diagnostic criteria and differential diagnosis].
    Cheng L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):199-202. PubMed ID: 24842024
    [No Abstract]   [Full Text] [Related]  

  • 15. Premalignancy in Prostate Cancer: Rethinking What we Know.
    De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
    Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penile metastases from intraductal carcinoma of prostate diagnosed by corpora cavernosa aspiration biopsy.
    Finkelstein LH; Manfrey SJ; Arsht DB; Bellin HJ
    J Am Osteopath Assoc; 1983 Apr; 82(8):549-50. PubMed ID: 6303990
    [No Abstract]   [Full Text] [Related]  

  • 17. A better understating of the morphological features and molecular characteristics of intraductal carcinoma helps clinicians further explain prostate cancer aggressiveness.
    Montironi R; Cheng L; Lopez-Beltran A; Scarpelli M; Montorsi F
    Eur Urol; 2015 Mar; 67(3):504-7. PubMed ID: 25194910
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoma of the prostate.
    Kopelson G
    N Engl J Med; 1979 Aug; 301(5):275. PubMed ID: 221815
    [No Abstract]   [Full Text] [Related]  

  • 19. Papillary carcinoma of prostatic ducts.
    Drake WM; Burrows S
    Urology; 1974 May; 3(5):621-3. PubMed ID: 4133858
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intraductal carcinoma of the prostate].
    Kristiansen G; Varma M; Seitz G
    Pathologe; 2016 Feb; 37(1):27-32. PubMed ID: 26782033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.